The Role of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in the Treatment of Heart Failure in Patients with Type 2 Diabetes Mellitus. Actual Problems of Medicine and Pharmacy, v. 3, n. 1, p. 1–10, 13 May2022.